SAN DIEGO, July 2, 2019 /PRNewswire/ — Immunicom, Inc., a biotechnology company awarded FDA Breakthrough Device Designation for its non-pharmaceutical solution for treating late-stage metastatic cancer, raised $11 million in a Series B investment r… […]
– Strategic financing to advance the commercialization of Evofem’s lead asset, Amphora® –
SAN DIEGO and INCLINE VILLAGE, Nev., June 10, 2019 /PRNewswire/ — Evofem Biosciences, Inc. (NASDAQ: EVFM) (Evofem), a clinical-stage biopharmaceutical company,… […]
Jeffrey M. Ostrove, Ph.D. named chief executive officerProprietary technology based on pioneering work from the lab of Eugene (Gene) Yeo, Ph.D. of UC San Diego
SAN DIEGO, May 22, 2019 /PRNewswire/ — Locana, Inc., a leading RNA-targeting gene therapy… […]
Up to $41.8 Million in Gross Proceeds to be Funded in Two Tranches
LA JOLLA, Calif., May 6, 2019 /PRNewswire/ — Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company focused on the discovery and development of innovative medicines t… […]
Funds will go toward recruiting top researchers and improving facilities in the South Bay region of LA County – one of the nation’s top ten biotech clusters
LOS ANGELES, Feb. 11, 2019 /PRNewswire/ — Southern California philanthropists Melanie and Ri… […]
SAN DIEGO, Nov. 28, 2018 /PRNewswire/ — MabVax Therapeutics Holdings, Inc. (OTC Pink: MBVX), a clinical-stage biotechnology company focused on the development of antibody-based products to address unmet medical needs in the treatment of cancer and… […]
Copyright © 2019 San Diego Biotechnology Network (DBA of Comprendia. LLC)
